Surgery, Gastroenterology and Oncology
Official journal of the International Association of Surgeons, Gastroenterologists and Oncologists
|
|
Whole Body MRI Evaluation in Patients with Multiple Myeloma: A Must
Magnetic resonance imaging (MRI) is increasingly used in the diagnosis of multiple myeloma (MM). The new statement of the International Myeloma Working Group (IMWG) introduced the role of Whole-body Magnetic Resonance Imaging (WB-MRI) in the management of patients with this haematological disease.
We report the case of a hospitalized patient in the haematology department, who was diagnosed with MM and investigated by WB-MRI in order to achieve a complete lesions report, and staging of the disease.
The presented case illustrates more lesions of the spine, long bones and the skull. Common MRI characteristics of MM lesions were defined as a nodular injuries, which were hypointense with T1-weighting, hyperintense with STIR and or hyperintense with b-800 diffusion-weighting.
WB-MRI examination was shown to be a sensitive imaging technique in evaluation of bone marrow and it was included in the Durie- Salmon staging system PLUS.
Full Text Sources:
Abstract:
Views: 3275
We report the case of a hospitalized patient in the haematology department, who was diagnosed with MM and investigated by WB-MRI in order to achieve a complete lesions report, and staging of the disease.
The presented case illustrates more lesions of the spine, long bones and the skull. Common MRI characteristics of MM lesions were defined as a nodular injuries, which were hypointense with T1-weighting, hyperintense with STIR and or hyperintense with b-800 diffusion-weighting.
WB-MRI examination was shown to be a sensitive imaging technique in evaluation of bone marrow and it was included in the Durie- Salmon staging system PLUS.
Full Text Sources:
Abstract:
Views: 3275
Watch Video Articles
For Authors
Journal Subscriptions
Current Issue
Dec 2025
Supplements
Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)
e-ISSN: 2601 - 1700 (online)
ISSN-L: 2559 - 723X
Journal Abbreviation: Surg. Gastroenterol. Oncol.
Surgery, Gastroenterology and Oncology (SGO) is indexed in:
e-ISSN: 2601 - 1700 (online)
ISSN-L: 2559 - 723X
Journal Abbreviation: Surg. Gastroenterol. Oncol.
Surgery, Gastroenterology and Oncology (SGO) is indexed in:
- SCOPUS
- EBSCO
- DOI/Crossref
- Google Scholar
- SCImago
- Harvard Library
- Open Academic Journals Index (OAJI)
Open Access Statement
Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.
Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.
Journal Metrics
Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2
Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2
IASGO Society News
Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.